Organometallics
Article
°C for 19 h. The solvent was removed in vacuo, and the apparatus was
brought into an inert-atmosphere glovebox. The crude residue was
washed with pentane (10 mL) to afford the title compound 8 as an off-
white solid that was used without further purification (980 mg, 91%).
1H NMR (CDCl3, 500 MHz): δ 11.00 (s, 1H), 7.44−7.43 (m, 2H),
7.06−7.00 (m, 6H), 5.50 (s, 4H), 2.51−2.43 (m, 4H), 1.82 (s, 6H),
1.09 (d, J = 7.1 Hz, 6H), 0.96 (d, J = 6.8 Hz, 6H). 13C NMR (CDCl3,
125 MHz): δ 163.00, 144.24, 140.06, 135.76, 124.40, 123.17, 122.76,
55.56, 28.32, 23.21, 22.70, 18.92. IR (neat) 3063, 2962, 2870, 1679,
1432, 1359, 1186, 1112, 1045, 784, 771, 751, 643 cm−1. HRMS (ESI
+): calcd for C33H47N4 [M + H]+ 499.3801, found 499.3798.
combined organics were dried over sodium sulfate, filtered, and
concentrated to afford the title compound 11 as a white solid (677 mg,
97%) that was used without further purification. H NMR (CDCl3,
1
500 MHz): δ 7.87 (s, 1H), 7.11−7.08 (m, 2H), 7.02 (dd, J = 8.6, 7.1
Hz, 1H), 3.87 (t, J = 6.1 Hz, 2H), 3.49 (t, J = 4.9 Hz, 2H), 2.77−2.68
(m, 2H), 1.99−1.94 (m, 2H), 1.89 (s, 3H), 1.13 (d, J = 6.8 Hz, 3H),
1.12 (d, J = 6.8 Hz, 3H). 13C NMR (CDCl3, 125 MHz): δ 152.30,
144.56, 144.20, 137.80, 123.16, 123.09, 44.68, 41.29, 28.32, 23.34,
23.08, 21.27, 15.23. IR (neat): 2957, 2920, 2850, 1620, 1458, 1380,
749 cm−1. HRMS (ESI+): calcd for C18H28N3 [M + H]+ 286.2283,
found 286.2279.
Synthesis of [N-1-[1-(2,6-Diisopropylphenylimino)ethyl]-N-
3-[2-(2,6-diisopropylphenylimino)propyl]imidazol-2-ylidene]-
iron(II) Chloride (9). In an inert-atmosphere glovebox, anhydrous
iron(II) dichloride (60.8 mg, 0.480 mmol, 0.500 equiv) was weighed
into a vial equipped with a magnetic stirbar. A solution of
Synthesis of N,N-1,3-Bis[1-(2,6-diisopropylphenylimino)-
ethyl]-4,5,6-trihydropyrimidinium Chloride (12). In an inert-
atmosphere glovebox, 1-[1-(2,6-diisopropylphenylimino)ethyl]-4,5,6-
trihydropyrimidine (11; 819 mg, 2.87 mmol, 1.00 equiv) was dissolved
in toluene (5.00 mL). A solution of N-(2,6-diisopropylphenyl)-
acetimidoyl chloride25 (682 mg, 2.87 mmol, 1.00 equiv) in toluene
(4.60 mL) was then added via pipet, and the solution was stirred at 23
°C for 20 min, during which time a white precipitate formed. The
solvent was removed in vacuo, and the crude solid was recrystallized
from dichloromethane layered with pentane at −40 °C. The colorless
crystals were filtered, washed with pentane (3 × 10 mL), and dried in
vacuo to deliver the title compound 12 as a crystalline white solid
20
[Fe(HMDS)2]2 (181 mg, 0.240 mmol, 0.250 equiv) in THF (7.30
mL) was added to the solid iron(II) dichloride via pipet, and the
suspension was stirred at 23 °C for 20 min. During this time, the
reaction mixture turned light brown and homogeneous. The solution
was diluted with additional THF (20.0 mL), and then a suspension of
imidazolium chloride 7 (500 mg, 0.959 mmol, 1.00 equiv) in THF
(20.8 mL) was added dropwise. Immediately upon addition, the
imidazolium salt dissolved and the reaction mixture turned yellow. The
solution was stirred for 2 h, and then the solvent was removed in
vacuo. The crude yellow solid was dissolved in dichloromethane,
layered with pentane, and cooled to −40 °C. The yellow crystals were
filtered, washed with pentane (3 × 5 mL), and dried in vacuo to
deliver the title complex 9 (297 mg, 51%). Crystals suitable for X-ray
crystallography were grown by vapor diffusion of pentane into a
solution of 9 in dichloromethane at −40 °C. IR (neat): 2961, 2868,
1678, 1634, 1435, 1394, 1365, 1300, 1253, 1214, 810, 782, 754, 733
cm−1. μeff = 5.0 μB at 25 °C (Evans method). Anal. Calcd for
C32H44Cl2FeN4: C, 62.86; H, 7.25; N, 9.16. Found: C, 62.89; H, 7.35;
N, 8.98.
1
(1.188 g, 79%). H NMR (CDCl3, 500 MHz): δ 9.88 (s, 1H), 7.18−
7.11 (m, 6H), 4.36 (t, J = 5.9 Hz, 4H), 2.78−2.70 (m, 4H), 2.61 (s,
6H), 2.49 (p, J = 5.9 Hz, 2H), 1.21 (d, J = 6.8 Hz, 6H), 1.13 (d, J = 6.8
Hz, 6H). 13C NMR (CDCl3, 125 MHz): δ 153.86, 153.34, 141.97,
136.83, 125.07, 123.48, 42.11, 28.49, 23.52, 23.02, 18.79, 16.23. IR
(neat): 2960, 2868, 1620, 1586, 1234, 1196, 764, 751 cm−1. HRMS
(ESI+): calcd for C32H47N4 [M]+ 487.3812, found 487.3801.
Synthesis of [N,N-1,3-Bis[1-(2,6-diisopropylphenylimino)-
ethyl]-4,5,6-trihydropyrimid-2-ylidene]iron Chloride (4). In an
inert-atmosphere glovebox, anhydrous iron(II) dichloride (79.8 mg,
0.630 mmol, 1.05 equiv) was suspended in THF (6.0 mL) and cooled
to −40 °C. To the cold suspension was then added dropwise a
precooled (−40 °C) solution of sodium hexamethyldisilazane (116
mg, 0.630 mmol, 1.05 equiv) in THF (9.6 mL), and the mixture was
held at −40 °C and agitated occasionally for 12 h.37 The mixture was
then warmed to 23 °C for 20 min, during which time most of the
remaining solid dissolved. The orange-brown solution was recooled to
−40 °C, filtered through Celite, and added to a precooled (−40 °C)
suspension of 12 (312 mg, 0.600 mmol, 1.00 equiv) in THF (6.0 mL).
The suspension was gradually warmed to 23 °C, during which time it
turned deep orange. The reaction mixture was then transferred to a
Schlenk tube, removed from the drybox, and heated to 50 °C for 24 h,
during which time the solution turned a dark wine red. The volatiles
were removed in vacuo, and the crude solid was brought back into the
glovebox. The crude residue was dissolved in a mixture of
dichloromethane and THF (ca. 10/1 v/v), filtered through Celite,
and concentrated. Recrystallization from THF layered with pentane at
−40 °C delivered a burgundy solid (200 mg, 54%). Dark red, X-ray-
quality crystals were then grown by submitting the collected solid to
recrystallization from a mixture of Et2O, CH2Cl2, and THF (2/3/2 v/
v) at −40 °C. IR (neat): 2959, 2866, 1612, 1560, 1389, 1322, 1291,
1206, 794, 769 cm−1. μeff = 5.0 μB at 25 °C (Evans method). Anal.
Calcd for C32H46Cl2FeN4: C, 62.65; H, 7.56; N, 9.13. Found: C, 61.57;
H, 7.48; N, 8.46.36
Synthesis of [N,N-1,3-Bis[2-(2,6-diisopropylphenylimino)-
propyl]imidazol-2-ylidene]iron(II) Chloride (10). In an inert-
atmosphere glovebox, anhydrous iron(II) dichloride (56.1 mg, 0.466
mmol, 0.500 equiv) was weighed into a vial equipped with a magnetic
20
stirbar. A solution of [Fe(HMDS)2]2 (175 mg, 0.233 mmol, 0.250
equiv) in THF (7.90 mL) was added to the solid iron(II) dichloride
via pipet, and the suspension was stirred at 23 °C for 20 min. During
this time, the reaction mixture turned light brown and homogeneous.
The solution was diluted with additional THF (20.0 mL), and then a
suspension of imidazolium chloride 8 (500 mg, 0.932 mmol, 1.00
equiv) in THF (19.6 mL) was added dropwise. Immediately upon
addition, the imidazolium salt dissolved and the reaction mixture
turned a yellow-orange. The solution was stirred for 2 h, and then the
solvent was removed in vacuo. The crude yellow solid was dissolved in
THF, layered with pentane, and cooled to −40 °C. The yellow crystals
were filtered, washed with pentane (3 × 5 mL), and dried in vacuo to
deliver the title complex 10 (212 mg, 35%). Crystals suitable for X-ray
crystallography were grown by vapor diffusion of pentane into a
solution of 10 in THF at 23 °C. IR (neat): 2961, 2869, 1666, 1639,
1460, 1438, 1366, 809, 780, 747 cm−1. μeff = 5.1 μB at 25 °C (Evans
method). Anal. Calcd for C33H46Cl2FeN4: C, 63.37; H, 7.41; N, 8.96.
Found: C, 62.28; H, 7.17; N, 8.46.36
Synthesis of N-1-[1-(2,6-Diisopropylphenylimino)ethyl]-
4,5,6-trihydropyrimidine (11). A solution of 1,4,5,6-tetrahydropyr-
imidine (0.201 mL, 2.45 mmol, 1.00 equiv) in THF (20.0 mL) was
cooled to −78 °C, and n-butyllithium in hexanes (1.00 mL, 2.57 mmol,
2.57 M, 1.05 equiv) was added dropwise, during which time a white
precipitate formed. The precipitate dissolved upon completion of the
addition, and the mixture was stirred for 20 min at −78 °C. To the
reaction mixture was then added a solution of N-(2,6-
diisopropylphenyl)acetimidoyl chloride25 (582 mg, 2.45 mmol, 1.00
equiv) in THF (4.0 mL) via cannula transfer. The solution was stirred
for 1 h at −78 °C and was then warmed to 23 °C and stirred for
another 1 h. The mixture was poured into water (40 mL), and the
product was extracted with dichloromethane (3 × 30 mL). The
ASSOCIATED CONTENT
■
S
* Supporting Information
1
Figures, tables, and CIF files giving H NMR spectra of 4, 9,
and 10 and crystallographic data for 4, 9, 10, and 13 (CCDC
reference numbers 900880−900883), including tables of crystal
data and structure refinement, bond lengths, angles, atomic
coordinates, equivalent isotropic displacement parameters, and
anisotropic displacement parameters. This material is available
7348
dx.doi.org/10.1021/om300885d | Organometallics 2012, 31, 7343−7350